| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |